SE8103904L - Stabiliserad beta-laktam - Google Patents

Stabiliserad beta-laktam

Info

Publication number
SE8103904L
SE8103904L SE8103904A SE8103904A SE8103904L SE 8103904 L SE8103904 L SE 8103904L SE 8103904 A SE8103904 A SE 8103904A SE 8103904 A SE8103904 A SE 8103904A SE 8103904 L SE8103904 L SE 8103904L
Authority
SE
Sweden
Prior art keywords
alpha
beta lactam
beta
stabilized beta
sugar
Prior art date
Application number
SE8103904A
Other languages
English (en)
Other versions
SE460702B (sv
Inventor
E Hirai
K Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of SE8103904L publication Critical patent/SE8103904L/sv
Publication of SE460702B publication Critical patent/SE460702B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8103904A 1980-06-23 1981-06-22 Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning SE460702B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
SE8103904L true SE8103904L (sv) 1981-12-24
SE460702B SE460702B (sv) 1989-11-13

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103904A SE460702B (sv) 1980-06-23 1981-06-22 Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning

Country Status (31)

Country Link
US (1) US4418058A (sv)
JP (1) JPS5711909A (sv)
KR (1) KR840000693B1 (sv)
AR (1) AR230007A1 (sv)
AT (1) AT380790B (sv)
AU (1) AU541627B2 (sv)
BE (1) BE889351A (sv)
BG (1) BG37991A3 (sv)
CA (1) CA1164801A (sv)
CH (1) CH648210A5 (sv)
CS (1) CS221835B2 (sv)
DD (1) DD159879A5 (sv)
DE (1) DE3124592A1 (sv)
DK (1) DK158443C (sv)
ES (1) ES503283A0 (sv)
FI (1) FI75490C (sv)
FR (1) FR2484835A1 (sv)
GB (1) GB2078737B (sv)
GR (1) GR75646B (sv)
HU (1) HU183494B (sv)
IE (1) IE51331B1 (sv)
IL (1) IL63136A (sv)
IT (1) IT1144812B (sv)
NL (1) NL191777C (sv)
NO (1) NO156036C (sv)
NZ (1) NZ197414A (sv)
PT (1) PT73239B (sv)
RO (1) RO82720B (sv)
SE (1) SE460702B (sv)
YU (1) YU44416B (sv)
ZA (1) ZA814203B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CN1556712A (zh) * 2000-07-13 2004-12-22 ��һ��������ҩ��ʽ���� 含dds化合物的药用组合物
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
EP2777705A1 (en) 2013-03-15 2014-09-17 Cubist Pharmaceuticals, Inc. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (sv) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
BE861876A (fr) * 1976-12-17 1978-06-15 Scherico Ltd Nouvelles formulations d'antibiotiques beta-lactame leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
IT8167863A0 (it) 1981-06-22
SE460702B (sv) 1989-11-13
PT73239B (en) 1982-07-22
ES8203887A1 (es) 1982-04-01
ES503283A0 (es) 1982-04-01
AR230007A1 (es) 1984-02-29
ZA814203B (en) 1982-09-29
NO156036B (no) 1987-04-06
GB2078737A (en) 1982-01-13
YU157381A (en) 1984-10-31
BG37991A3 (en) 1985-09-16
FI811948L (fi) 1981-12-24
CH648210A5 (de) 1985-03-15
NO156036C (no) 1987-07-15
FI75490C (sv) 1988-07-11
JPS5711909A (en) 1982-01-21
RO82720A (ro) 1984-05-23
FR2484835A1 (fr) 1981-12-24
US4418058A (en) 1983-11-29
FI75490B (fi) 1988-03-31
CA1164801A (en) 1984-04-03
NL191777B (nl) 1996-04-01
DE3124592A1 (de) 1982-02-11
AT380790B (de) 1986-07-10
KR840000693B1 (ko) 1984-05-21
YU44416B (en) 1990-08-31
DE3124592C2 (sv) 1990-12-20
PT73239A (en) 1981-07-01
DK158443C (da) 1990-10-08
NL191777C (nl) 1996-08-02
GR75646B (sv) 1984-08-02
IE51331B1 (en) 1986-12-10
BE889351A (fr) 1981-10-16
KR830005848A (ko) 1983-09-14
IL63136A (en) 1984-07-31
IT1144812B (it) 1986-10-29
NZ197414A (en) 1984-10-19
AU7209781A (en) 1983-01-06
DK274981A (da) 1981-12-24
NL8102943A (nl) 1982-01-18
DK158443B (da) 1990-05-21
AU541627B2 (en) 1985-01-17
ATA278881A (de) 1985-12-15
CS221835B2 (en) 1983-04-29
IE811347L (en) 1981-12-23
HU183494B (en) 1984-05-28
DD159879A5 (de) 1983-04-13
FR2484835B1 (sv) 1983-07-01
JPS6364405B2 (sv) 1988-12-12
IL63136A0 (en) 1981-09-13
RO82720B (ro) 1984-07-30
GB2078737B (en) 1984-03-14
NO812090L (no) 1981-12-28

Similar Documents

Publication Publication Date Title
SE8103904L (sv) Stabiliserad beta-laktam
GB8826066D0 (en) New use of 11 28-dioxa-4-azatricyclo(22 3 1 0 4.9)octacos-18-ene derivatives & pharmaceutical compositions
ATE52033T1 (de) Verfahren zur herstellung eines lyophilisierten radiografischen abbildungsbestecks.
IL97826A0 (en) Ammonium salts of n5,-methyl-5,6,7,8-tetrahydrofolic acid,their preparation and pharmaceutical compositions containing them
EP0142335A3 (en) Lactam containing compounds
IL87490A0 (en) Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism
ES8305769A1 (es) Un procedimiento para la preparacion de bis-esteres de 1,1-alcanodioles.
JPS57158742A (en) Stabilization of acetoacetamide aqueous solution
AU552681B2 (en) Composition containing glycyrrhetinic acid or derivatives
JPS539783A (en) Stabilized composition containing cyanuric acid derivatives
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
PT74412B (en) Process for the preparation of an herbicidal composition cont- taining substituted tetrahydropyrimidinone derivatives
AU578335B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
IT1148165B (it) Procedimento per la produzione di sodio amossicillina
PT74295A (en) Improved process for the preparation of 7-<(carboxymethoxyimi- no)-1h-pyrazol-3-yl>-amino-3-deacetoxy-3-(1-methyl-1h-tetrazol--5-yl-thio)-cephalosporanic acid
AU551219B2 (en) 5-0-mycaminosyl tylonolide treatment of pasturella infections
ES542611A0 (es) Procedimiento de preparacion de nuevas composiciones sinergeticas antimicrobianas que contienen aritetraciclina y un acido organico de acitividad antimicrobiana.
NO162463C (no) Mellomprodukter for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)-eddiksyre.
PH16897A (en) 1,3-thiazolidine-4-yl-carboxylic acid derivatives of penicillanic acid and pharmaceutical compositions containing the same
ES514355A0 (es) Procedimiento de preparacion de derivados del acido fenoxi- benzoico.
EP0291436A3 (en) Process for the preparation of heptaminol adenosine-5'-monophase by atomisation of an aqueous solution containing it
JPS57137999A (en) Monitor for inside of vehicle by picture

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8103904-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8103904-2

Format of ref document f/p: F